Patricia Acevedo
Primary Care · Dover, NJNPI 1497411979
Payments from drug & device makers
Across 80 payments — averaging $26.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$622
- Novo Nordisk$589
- Halozyme Inc$161
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$112
- Pfizer$85
- Paratek Pharmaceuticals, Inc.$51
- plus $475 from 22 others
What the payments were for
- Food & beverage$2,094100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 9 | $622 |
| Novo Nordisk | 23 | $589 |
| Halozyme Inc | 6 | $161 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $112 |
| Pfizer | 5 | $85 |
| Paratek Pharmaceuticals, Inc. | 3 | $51 |
| Baxter Healthcare | 2 | $43 |
| Organon | 1 | $37 |
| Bayer | 2 | $36 |
| Amarin Pharma, Inc. | 2 | $32 |
| Xeris Pharmaceuticals, Inc. | 2 | $30 |
| Tolmar, Inc. | 2 | $28 |
| Exact Sciences | 1 | $26 |
| Renalytix AI, Inc. | 1 | $21 |
| Corcept Therapeutics | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Amgen | 1 | $18 |
| Novartis | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| GSK | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Lifescan, Inc. | 1 | $14 |
| Antares Pharma, Inc. | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Endo Pharmaceuticals Inc. | 1 | $13 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Embecta Corp. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,094 in reported general payments places this provider in the 80th percentile of 330 primary care providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 29 | $61,223 |
| JanuviaSitagliptin Phosphate | 16 | $24,456 |
| FarxigaDapagliflozin Propanediol | 19 | $23,927 |
| Omeprazole | 117 | $1,467 |
| Levothyroxine Sodium | 104 | $1,379 |
| Atorvastatin Calcium | 110 | $1,082 |
| Rosuvastatin Calcium | 52 | $991 |
| Cyanocobalamin InjectionCyanocobalamin (Vitamin B-12) | 20 | $697 |
| Metoprolol Succinate | 44 | $643 |
| Duloxetine Hcl | 28 | $616 |
| Diclofenac Sodium | 23 | $596 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $542 |
| Fluticasone Propionate | 26 | $455 |
| Amlodipine Besylate | 56 | $432 |
| Metformin Hcl | 65 | $393 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $589 | $61,22329 claims |
| AstraZenecaFarxiga | $622 | $23,92719 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 330 primary care providers in New Jersey.
Other primary care in Dover
- Michael Zito GovertNeptune$61K
- Roseann BenantiEnglewood$24K
- Marcelo MarinEnglewood$17K
- Jennifer EdwardsPrinceton$14K
- Mary Grace TolentinoJersey City$9K
- Kevin Robert ReyladoNorth Arlington$8K
- Carlo SebelloJersey City$8K
- Karam WehbehPaterson$7K
- Shazam BacchusNewark$7K
- Anna NievesBasking Ridge$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.